nitroblue tetrazolium has been researched along with uracil in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Honma, Y; Ishikawa, I; Kanatani, Y; Kawahara, N; Makishima, M; Motoyoshi, K; Nagata, N; Ogasawara, Y | 1 |
1 other study(ies) available for nitroblue tetrazolium and uracil
Article | Year |
---|---|
A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Topics: Antimetabolites, Antineoplastic; Calcitriol; Cell Differentiation; Cell Nucleus; DNA-Binding Proteins; Growth Inhibitors; HL-60 Cells; Humans; Leukemia, Myeloid; Nitroblue Tetrazolium; Oxidoreductases; Receptors, Calcitriol; Receptors, Retinoic Acid; Retinoid X Receptors; Transcription Factors; Tretinoin; Tumor Cells, Cultured; Uracil | 1998 |